140 related articles for article (PubMed ID: 20304996)
1. Identification of a novel estrogen receptor-alpha variant and its upstream splicing regulator.
Ohshiro K; Mudvari P; Meng QC; Rayala SK; Sahin AA; Fuqua SA; Kumar R
Mol Endocrinol; 2010 May; 24(5):914-22. PubMed ID: 20304996
[TBL] [Abstract][Full Text] [Related]
2. IQGAP1 modulates the proliferation and invasion of thyroid cancer cells in response to estrogen.
Meng D; Wu W; Li Z; Qin G
Int J Mol Med; 2015 Aug; 36(2):588-94. PubMed ID: 26046126
[TBL] [Abstract][Full Text] [Related]
3. Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs.
Madak-Erdogan Z; Lupien M; Stossi F; Brown M; Katzenellenbogen BS
Mol Cell Biol; 2011 Jan; 31(1):226-36. PubMed ID: 20956553
[TBL] [Abstract][Full Text] [Related]
4. Bisphenol AF-induced endogenous transcription is mediated by ERα and ERK1/2 activation in human breast cancer cells.
Li M; Guo J; Gao W; Yu J; Han X; Zhang J; Shao B
PLoS One; 2014; 9(4):e94725. PubMed ID: 24727858
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor α (ERα) mediates 17β-estradiol (E2)-activated expression of HBO1.
Wang WZ; Liu HO; Wu YH; Hong Y; Yang JW; Liu YH; Wu WB; Zhou L; Sun LL; Xu JJ; Yun XJ; Gu JX
J Exp Clin Cancer Res; 2010 Nov; 29(1):140. PubMed ID: 21040551
[TBL] [Abstract][Full Text] [Related]
6. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
7. A cytoplasmic substrate of mitogen-activated protein kinase is responsible for estrogen receptor-alpha down-regulation in breast cancer cells: the role of nuclear factor-kappaB.
Holloway JN; Murthy S; El-Ashry D
Mol Endocrinol; 2004 Jun; 18(6):1396-410. PubMed ID: 15056731
[TBL] [Abstract][Full Text] [Related]
8. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
[TBL] [Abstract][Full Text] [Related]
9. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity.
Thomas RS; Sarwar N; Phoenix F; Coombes RC; Ali S
J Mol Endocrinol; 2008 Apr; 40(4):173-84. PubMed ID: 18372406
[TBL] [Abstract][Full Text] [Related]
11. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
Nakuci E; Mahner S; Direnzo J; ElShamy WM
Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
[TBL] [Abstract][Full Text] [Related]
12. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
Teng J; Wang ZY; Jarrard DF; Bjorling DE
Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301
[TBL] [Abstract][Full Text] [Related]
13. Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells.
Gong EY; Park E; Lee K
Cancer Sci; 2010 Sep; 101(9):2019-25. PubMed ID: 20608937
[TBL] [Abstract][Full Text] [Related]
14. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
15. Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cells.
Lal S; Allan A; Markovic D; Walker R; Macartney J; Europe-Finner N; Tyson-Capper A; Grammatopoulos DK
Sci Signal; 2013 Jul; 6(282):ra53. PubMed ID: 23821771
[TBL] [Abstract][Full Text] [Related]
16. Heregulin controls ERα and HER2 signaling in mammospheres of ERα-positive breast cancer cells and interferes with the efficacy of molecular targeted therapy.
Fukui F; Hayashi SI; Yamaguchi Y
J Steroid Biochem Mol Biol; 2020 Jul; 201():105698. PubMed ID: 32404282
[TBL] [Abstract][Full Text] [Related]
17. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Gefitinib-mediated reversal of tamoxifen resistance in MCF-7 breast cancer cells by inducing ERα re-expression.
Zhang X; Zhang B; Liu J; Liu J; Li C; Dong W; Fang S; Li M; Song B; Tang B; Wang Z; Zhang Y
Sci Rep; 2015 Feb; 5():7835. PubMed ID: 25644501
[TBL] [Abstract][Full Text] [Related]
19. RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1.
Gustafsson N; Zhao C; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2010 Feb; 70(3):1265-74. PubMed ID: 20103625
[TBL] [Abstract][Full Text] [Related]
20. Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells.
Oh AS; Lorant LA; Holloway JN; Miller DL; Kern FG; El-Ashry D
Mol Endocrinol; 2001 Aug; 15(8):1344-59. PubMed ID: 11463858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]